Oral Semaglutide 25 mg Matched SC Exposure in Obesity With and Without T2DM Tags GLP-1 agonists Read more about Oral Semaglutide 25 mg Matched SC Exposure in Obesity With and Without T2DM
Tirzepatide Outperformed Dulaglutide for MACE in T2DM With ASCVD Tags Coronary artery disease GLP-1 agonists Read more about Tirzepatide Outperformed Dulaglutide for MACE in T2DM With ASCVD
NAION Risk Increased After GLP-1 RA Start in T2DM Tags Nonarteritic Ischemic Optic Neuropathy GLP-1 agonists DPP-4 inhibitors Read more about NAION Risk Increased After GLP-1 RA Start in T2DM
Semaglutide Showed Strong Metabolic Benefits in Schizophrenia Tags GLP-1 agonists Read more about Semaglutide Showed Strong Metabolic Benefits in Schizophrenia
Global Safety Review Flags Drug-Specific Risks With GLP-1 RAs Tags GLP-1 agonists Read more about Global Safety Review Flags Drug-Specific Risks With GLP-1 RAs
Semaglutide Lowered Insulin Dose in Type 1 Diabetes with Obesity Tags GLP-1 agonists Read more about Semaglutide Lowered Insulin Dose in Type 1 Diabetes with Obesity
GLP-1 RAs Use Show Higher NAION Risk in Meta-Analysis Tags Nonarteritic Ischemic Optic Neuropathy GLP-1 agonists Read more about GLP-1 RAs Use Show Higher NAION Risk in Meta-Analysis
GLP-1 Therapies Lower Major Limb Events in PAD Tags Coronary artery disease Peripheral vascular disease Myocardial infarction Stroke GLP-1 agonists Read more about GLP-1 Therapies Lower Major Limb Events in PAD
Early CKM Patients on Tirzepatide Had Fewer CV Events Tags Peripheral vascular disease Coronary artery disease GLP-1 agonists Read more about Early CKM Patients on Tirzepatide Had Fewer CV Events
Semaglutide Shows Strong HbA1c, Weight Effects in Young T2DM Adults Tags hBA1c GLP-1 agonists Read more about Semaglutide Shows Strong HbA1c, Weight Effects in Young T2DM Adults